The Winter 2024 edition of the NIHR UCLH Clinical Research Facility’s (CRF) early phase cancer trials newsletter is out now.
In this edition:
Dr Sarah Benafif reflects on the first UK lung cancer patient to receive a novel immune therapy at the CRF
The team looks back at 2024 in review in early phase cancer trials at the CRF
Jamie Adams looks at the vital role of clinical pharmacists in research
Dr William Townsend and Dr Rakesh Popat outline the importance of bispecific antibodies, a new class of immunotherapy treatment which have shown remarkable efficacy in some cancers
And more.
